Skip to content
Menu
Menu
About Us
Investment Approach
Investment Options
Valcreate Growing India
IME Concentrated Microtrends
Valcreate Life Sciences & Speciality
IME Digital Disruption
Media
Blog
Media Interviews
Press Articles
Contact Us
IT, pharma likely to be biggest beneficiaries of FII inflows. Here’s why
